Notice: Undefined index: super-video-player/freemius in /home/kerman/public_html/wp-content/plugins/easy-newsletter-signups/freemius/start.php on line 184

Notice: Trying to get property of non-object in /home/kerman/public_html/wp-content/plugins/easy-newsletter-signups/freemius/start.php on line 189

Notice: Undefined index: super-video-player/freemius in /home/kerman/public_html/wp-content/plugins/easy-newsletter-signups/freemius/start.php on line 277
Kerman & Co. | Robert Paydon Robert Paydon – Kerman & Co.
Robert Paydon
Robert Paydon
Head of Commercial Litigation

Robert is an experienced commercial litigation/dispute resolution lawyer and advises on a wide range of contentious matters, including in the pharmaceutical/life sciences, manufacturing, natural resources and property sectors. He deals with contractual, company and shareholder disputes as well as regulatory issues (for example matters concerning the UK’s Pharmaceutical Price Regulation Schemes and advertising). Robert acts for clients from the UK and overseas and much of his work has a multi-jurisdictional aspect.

Robert has advised on a range of insolvency issues and acts for creditors, debtors and office holders, and he is also concerned with the protection and management of corporate and individual reputations (particularly through the law of defamation, privacy and data protection).

Robert’s experience covers the full extent of the litigation process, from risk management and pre-action advice through to obtaining and resisting interim orders, trial, proceedings in the appellate courts and enforcement, as well as significant involvement in international arbitration and ADR processes: mediation and expert determination (both as party adviser and as counsel to the expert).

Robert is named as a recognised lawyer in the field of Commercial Litigation in the 2021 edition of the Legal 500.

Representative experience includes:

  • Acted for a natural resources company in US $ 200m LCIA arbitration proceedings concerning a breach of contract.
  • Acted for a defendant in US $ 100m proceedings in the English Commercial Court.
  • Acted for a company in connection with ‘preference’ and ‘undervalue transaction’ claims threatened against it by an administrator.
  • Advised a UK pharmaceutical company concerning defamatory reporting in the media about one of its key products.
  • Advised an overseas company concerning an issue arising out of its proposed social media campaign.
  • Advised a HNW individual in a significant multi-jurisdictional shareholders dispute.
  • Advised on a high value dispute concerning the division of a multinational business (with parallel proceedings in the High Court in London and in various US states).
  • Advised several pharmaceutical companies about matters concerning the UK’s Pharmaceutical Price Regulation Schemes.
  • Acted in connection with the registration and enforcement of various foreign judgments.

Latest News

November 13, 2020

New National Security and Investment Bill means tougher screening measures for investment into UK Companies

Read more
November 12, 2020

COVID-19 Update: Coronavirus Job Retention Scheme - updated guidance

Read more
November 6, 2020

COVID-19 Update: Coronavirus Job Retention Scheme: Extension

Read more
How can we help?

Would you like our experts to assist you with your legal requirements?

  • By completing this form you agree to your details being used to email you the information requested in accordance with our Privacy Policy.